Abstract
This study reports the use of chitosan microcapsules for daunorubicin delivery via an oral route. The potential oral delivery of the daunorubicin/chitosan microcapsules was examined using an in vivo athymic nude mice xenograft model with Non-Hodgkin's lymphoma cells. Microencapsulated daunorubicin could be administered orally with tumour growth inhibition activity.
| Original language | English |
|---|---|
| Pages (from-to) | 14109-14114 |
| Number of pages | 6 |
| Journal | RSC Advances |
| Volume | 4 |
| Issue number | 27 |
| DOIs | |
| Publication status | Published - 1 Jan 2014 |
ASJC Scopus subject areas
- General Chemistry
- General Chemical Engineering
Fingerprint
Dive into the research topics of 'The development of chitosan based microcapsules as delivery vehicles for orally administered daunorubicin'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver